PV
Although JAK2(V617F) transcript levels did not decrease upon exposure to dasatinib, the drug might suppress PV progenitors through inhibition of a yet undefined molecular target.
Although <span class="gene" id="18717827-14-9-13">JAK2</span>(V617F) transcript levels did not decrease upon exposure to dasatinib, the drug might suppress <span class="disease" id="18717827-14-108-110">PV</span> progenitors through inhibition of a yet undefined molecular target.